Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nanomedicine | 2 | 2020 | 329 | 0.76 | Why? |
| Liposomes | 1 | 2021 | 334 | 0.76 | Why? |
| Cell-Free Nucleic Acids | 1 | 2021 | 271 | 0.70 | Why? |
| Extracellular Vesicles | 1 | 2021 | 607 | 0.54 | Why? |
| Microscopy | 1 | 2017 | 414 | 0.53 | Why? |
| Proteolysis | 1 | 2017 | 751 | 0.52 | Why? |
| Cell Phone | 1 | 2017 | 750 | 0.40 | Why? |
| Peptide Hydrolases | 1 | 2017 | 1269 | 0.39 | Why? |
| Smartphone | 1 | 2021 | 1840 | 0.38 | Why? |
| Nanoparticles | 2 | 2020 | 2040 | 0.38 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.36 | Why? |
| CRISPR-Cas Systems | 4 | 2021 | 1397 | 0.36 | Why? |
| Macrophages | 1 | 2020 | 2784 | 0.36 | Why? |
| Biosensing Techniques | 3 | 2021 | 2116 | 0.35 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.34 | Why? |
| Endocytosis | 2 | 2020 | 451 | 0.29 | Why? |
| Peptides | 1 | 2017 | 2513 | 0.29 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.28 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.27 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.26 | Why? |
| Tetraspanin 28 | 1 | 2021 | 38 | 0.23 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.21 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.18 | Why? |
| Cytarabine | 1 | 2017 | 64 | 0.17 | Why? |
| Cell Cycle Checkpoints | 1 | 2017 | 126 | 0.16 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2017 | 99 | 0.16 | Why? |
| Hydrogen-Ion Concentration | 1 | 2020 | 993 | 0.15 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.15 | Why? |
| Animals | 5 | 2021 | 78931 | 0.13 | Why? |
| Aptamers, Nucleotide | 1 | 2017 | 265 | 0.13 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.12 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2021 | 1439 | 0.12 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.12 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.12 | Why? |
| Virion | 1 | 2020 | 1444 | 0.11 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.11 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.09 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.09 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.08 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.08 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 2426 | 0.08 | Why? |
| Universities | 1 | 2021 | 4374 | 0.08 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.07 | Why? |
| False Negative Reactions | 2 | 2021 | 1785 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 13720 | 0.06 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.06 | Why? |
| Humans | 13 | 2021 | 930598 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| Protease Inhibitors | 1 | 2017 | 3630 | 0.05 | Why? |
| Leukemia, B-Cell | 1 | 2020 | 50 | 0.05 | Why? |
| Louisiana | 1 | 2021 | 353 | 0.05 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Infant | 1 | 2021 | 30274 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.04 | Why? |
| Allografts | 1 | 2020 | 761 | 0.04 | Why? |
| Fluorescent Dyes | 1 | 2020 | 536 | 0.04 | Why? |
| Immunoglobulins | 1 | 2020 | 811 | 0.04 | Why? |
| Genes, Viral | 1 | 2020 | 1428 | 0.03 | Why? |
| Immunization, Passive | 2 | 2020 | 10067 | 0.03 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2020 | 676 | 0.03 | Why? |
| Male | 4 | 2021 | 367725 | 0.03 | Why? |
| Female | 4 | 2021 | 380317 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Child | 1 | 2021 | 70012 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3633 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2017 | 3608 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Adult | 1 | 2021 | 244371 | 0.02 | Why? |
| Students | 1 | 2021 | 5255 | 0.02 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
Hu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_